ArticleCureus2025
Bilateral Cerebellopontine Angle Masses in a 72-Year-Old Woman With Prior Malignant Melanoma and a Cochlear Implant: A Diagnostic and Management Challenge.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cerebellopontine angle masses are most frequently vestibular schwannomas, but may also represent metastatic disease, particularly in patients with a history of malignant melanoma. We describe the case of a 72-year-old woman with a prior history of melanoma and a right cochlear implant who presented with rapidly progressive bilateral hearing loss, visual impairment, imbalance, and right-sided facial weakness. An initial non-contrast CT scan was reported as normal, although a later multidisciplinary review identified bilateral cerebellopontine angle lesions. MRI, the gold standard for characterising lesions of this region, could not be performed because of the cochlear implant. The differential diagnosis included bilateral vestibular schwannomas and metastatic melanoma. During hospitalisation, the patient developed an infection that resolved with antibiotic therapy but continued to deteriorate neurologically, with worsening visual loss and recurrent falls. A repeat contrast-enhanced CT scan demonstrated enlargement of the cerebellopontine angle lesions with associated cerebral oedema and ventricular dilatation. Her past genetic testing had confirmed BRAF positivity, though her frailty and poor functional status excluded neurosurgical or targeted systemic treatment. Following multidisciplinary and family discussions, palliative care was initiated. The patient experienced progressive decline and died 45 days after admission. This case illustrates the diagnostic and therapeutic challenges associated with bilateral cerebellopontine angle lesions in patients with a history of melanoma when MRI is contraindicated. It highlights the aggressive behaviour of melanoma metastases, the limitations in imaging and treatment options in frail patients with implants, and the importance of involving palliative care early to optimise symptom management and family support.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.